A look back at the contributions of UF’s Emerging Pathogens Institute to campus-wide COVID-19 research.
ntists can grow individual cell lines in a dish and study how the coronavirus infects them. And that’s useful as far as it goes. In a sense, however, it’s like studying how a car works by looking at just the carburetor. To gain the most insight, researchers want to study human lung tissue in its full, multidimensional glory, with all cell types represented.
Small-scale grower operations have their advantages despite being challenged by access to large markets and limits on resources. In urban and rural environments, challenges that emerged from COVID-19 brought small-scale farms to light.
A team of virologists who study viruses in bats work toward a test for a public health study to understand its development in older adults.
Millions of isolated people have found comfort by chatting with an AI bot. Therapeutic bots have improved users’ mental health for decades.
An editorial by UF professors, published in the American Journal of Public Health, casts a spotlight on the plight of guest agricultural workers during the pandemic.
Gabriela Hamerlinck teaches about pandemics at UF.
Xiaochen Xian, Ph.D., an assistant professor for UF ISE, is working on research to develop a way to administer mass testing for COVID-19.
UF Engineering researcher Eric Jing Du received a NSF RAPID Grant to study how people can have improved responses to future global crises.
As part of the White House’s Operation Warp Speed initiative, the U.S. Department of Health and Human Services selected UF Health and...
A team of volunteer UF Health medical professionals together with personnel from The Villages Health primary care network evaluated 2,280 people.
Patients with severe cases of COVID-19 who were treated with the investigational drug remdesivir recovered faster than those who did not take it, based on results released this week of an international clinical trial that included UF Health.